Stage IV Adult Diffuse Large Cell Lymphoma Terminated Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0028711 (Stage IV Adult Diffuse Large Cell Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment
NCT00080847S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's LymphomaTreatment